Funding Update
30 Enero 2009 - 1:00AM
UK Regulatory
TIDMAMP
RNS Number : 4986M
Amphion Innovations PLC
30 January 2009
Amphion Innovations plc
Funding Update
London and New York, 30 January 2009 - Amphion Innovations plc (LSE: AMP)
("Amphion" or the "Company"), the developer of medical and technology
businesses, today announces that it has received a further subscription of
GBP408,750 for the Convertible Promissory Note, first announced on 31 December
2008. This brings the total amount issued to GBP2,599,650 on the same terms as
previously announced.
For further information please contact
Amphion Innovations
Charlie Morgan
+1 212 210 6224
Cardew Group
Tim Robertson/ Jamie Milton/ Matthew Law
+44 20 7930 0777
Charles Stanley (Nominated Adviser)
Mark Taylor/ Freddy Crossley
+44 20
7149 6000
About Amphion Innovations plc
Amphion (LSE: AMP) builds shareholder value in high growth companies in the
medical and technology sectors, by using a focused, hands-on company building
approach, based on decades of experience in both the US and UK. Amphion has
significant shareholding in 8 Partner Companies, developing proven technologies
targeting substantial commercial marketplaces, each in excess of $1 billion.
Each Partner Company is chosen with the goal of achieving an exit valuation in
excess of $100 million.
On the web: www.amphionplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCSEAFWUSUSEEF
Amphion Innovations (LSE:AMP)
Gráfica de Acción Histórica
De Jul 2024 a Ago 2024
Amphion Innovations (LSE:AMP)
Gráfica de Acción Histórica
De Ago 2023 a Ago 2024
Real-Time news about Amphion Innovations Plc (London Stock Exchange): 0 recent articles
Más de Amphion Innovations Artículos de Noticias